Home/Filings/4/0000059478-24-000082
4//SEC Filing

Zakrowski Donald A 4

Accession 0000059478-24-000082

CIK 0000059478other

Filed

Mar 10, 8:00 PM ET

Accepted

Mar 11, 4:27 PM ET

Size

9.8 KB

Accession

0000059478-24-000082

Insider Transaction Report

Form 4
Period: 2024-02-12
Zakrowski Donald A
Chief Accounting Officer
Transactions
  • Sale

    Common Stock

    2024-03-11$753.60/sh750$565,2007,880 total
  • Award

    Restricted Stock Unit

    2024-02-12+184184 total
    From: 2026-02-16Exp: 2026-02-16Common Stock (184 underlying)
  • Award

    Restricted Stock Unit

    2024-02-12+186186 total
    From: 2027-02-16Exp: 2027-02-16Common Stock (186 underlying)
Holdings
  • Common Stock

    (indirect: By 401(k))
    1,710
Footnotes (2)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2023.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. These grants were inadvertently omitted from the reporting person's Form 4 filed on February 14, 2024.

Issuer

ELI LILLY & Co

CIK 0000059478

Entity typeother

Related Parties

1
  • filerCIK 0001561539

Filing Metadata

Form type
4
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 4:27 PM ET
Size
9.8 KB